Kingsmore Biotech, LLC — Form D/A
Kingsmore Biotech, LLC of MIAMI BEACH, FL, a company, filed a Form D amendment with the SEC on 2017-07-18. The offering totals $478K, of which $478K was reported sold. Industry: Other.
Offering
- Filed: 2017-07-18
- Form: D/A
- Accession: 0001701426-17-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $478K
- Amount sold: $478K
- Minimum investment: $1
- Investors: 41
- Date of first sale: 2017-03-17
- Revenue range: Decline to Disclose
- SEC file number: 021-283925
Issuer
- Name: Kingsmore Biotech, LLC
- CIK: 0001701426
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 5251 LAGORCE DRIVE, MIAMI BEACH, FL, 33140
- Phone: 305-401-4148
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Kelley Dalby | Director | Miami Beach, FL |
| Alex Nemiroff | Director | Miami Beach, FL |
Other filings by this issuer (1)
More